Next Quarterly Earnings
Monday, November 16, 2026
CW 47
After-Hours
In 81 days
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Mineralys Therapeutics
Mineralys Therapeutics is a US-based biopharmaceutical company specializing in the development of innovative treatments for hypertension and cardiovascular diseases. The company focuses on the precise regulation of aldosterone levels to improve therapeutic outcomes for patients with these conditions.
Frequently asked questions
When will Mineralys Therapeutics report its next quarterly earnings?
Mineralys Therapeutics is scheduled to report its next quarterly earnings on 11/16/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
When did Mineralys Therapeutics last report quarterly earnings?
Mineralys Therapeutics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -2.85 USD.
How does Mineralys Therapeutics stock react to earnings?
Across its last 3 earnings reports, Mineralys Therapeutics stock moved by ±2.2% on average the following day. The largest reaction was -3% on 03/12/2026; 0 of 3 reactions were positive.
How often has Mineralys Therapeutics beaten expectations?
Mineralys Therapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
How do I add the Mineralys Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±2.2%
Avg. next-day move
-3%
Largest move (03/12/2026)
0%
Share of positive reactions
±9.1%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
4/5
Quarters above estimates
80%
Beat rate
-79.1%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Mineralys Therapeutics
Country
🇺🇸
More Financial Information